P3 Health Partners (PIII) Gains from Investment Securities (2019 - 2025)

P3 Health Partners has reported Gains from Investment Securities for 7 years, with the latest figure at -$12.3 million in Q4 2025.

• For the quarter ending Q4 2025, Gains from Investment Securities fell 12252.48% year-over-year to -$12.3 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 million (up 117.96% YoY), and the FY2024 full-year result was $103000.0, up 543.75% from the prior year.
• Gains from Investment Securities for Q4 2025 stood at -$12.3 million, down from $2.5 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $14.3 million in Q1 2025, with the low at -$12.3 million in Q4 2025.
• Historically, Gains from Investment Securities has averaged -$957502.6 across 5 years, with a median of -$311000.0 in 2023.
• The largest YoY upside for Gains from Investment Securities was 6741.2% in 2025 against a maximum downside of 12252.48% in 2025.
• P3 Health Partners' Gains from Investment Securities stood at -$5.5 million in 2021, then soared by 168.63% to $3.8 million in 2022, then plunged by 108.21% to -$311000.0 in 2023, then soared by 132.48% to $101000.0 in 2024, then slumped by 12252.48% to -$12.3 million in 2025.
• The last three Gains from Investment Securities figures came in at -$12.3 million (Q4 2025), $2.5 million (Q3 2025), and -$2.0 million (Q2 2025), per Business Quant data.